Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY Legend Capital Aug 19, 2022 17:55 HKT/SGT Read More
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業 Taiwan Excellence Awards Aug 19, 2022 14:01 HKT/SGT Read More
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業 Taiwan Excellence Awards Aug 19, 2022 14:01 HKT/SGT Read More
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022 Taiwan Excellence Awards Aug 19, 2022 14:00 HKT/SGT Read More
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022 Taiwan Excellence Awards Aug 19, 2022 14:00 HKT/SGT Read More
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU Malaysian Genomics Resource Centre Bhd Aug 18, 2022 18:00 HKT/SGT Read More
Essex Bio-Technology Included in "Forbes Asia's Best Under A Billion 2022" Essex Bio-Technology Limited Aug 16, 2022 09:00 HKT/SGT Read More
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully Legend Capital Aug 15, 2022 16:50 HKT/SGT Read More
Yunkang Group Announces First Interim Results Since Listing, Net Profit Rises 50% to RMB234 Million Yunkang Group Limited Aug 12, 2022 09:00 HKT/SGT Read More
Sisram Medical 1H2022 Results Conf Call on Aug 22 at 8:30am ET Sisram Medical Ltd Aug 11, 2022 10:07 HKT/SGT Read More
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans PCG Digital Aug 09, 2022 20:30 HKT/SGT Read More
Eisai and Lifenet Enter Into Capital and Business Alliance Agreement Aimed at Building Ecosystem to Reduce Burden of Medical and Nursing Care Eisai Aug 09, 2022 17:09 HKT/SGT Read More
Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully Legend Capital Aug 09, 2022 13:06 HKT/SGT Read More
エーザイ、「レカネマブ」について皮下注射製剤およびApoE4遺伝子型によるARIA-E発現に関するモデリング・シミュレーションに関する知見をAAIC 2022にて発表 Eisai Aug 04, 2022 10:00 JST Read More
Eisai Presents New Findings on Lecanemab's Investigational Subcutaneous Formulation and Modeling Simulation of ApoE4 Genotype on Aria-E Incidence at AAIC 2022 Eisai Aug 04, 2022 08:25 HKT/SGT Read More